Yashi Cao , Zengyue Pan , Xiner Shen , Zhifei Xu , Xiaochun Yang , Bo Yang , Peihua Luo , Hao Yan , Qiaojun He
{"title":"CAMK2G在亚细胞Ca2+稳态中的作用:分子机制和治疗靶向。","authors":"Yashi Cao , Zengyue Pan , Xiner Shen , Zhifei Xu , Xiaochun Yang , Bo Yang , Peihua Luo , Hao Yan , Qiaojun He","doi":"10.1016/j.bcp.2025.117323","DOIUrl":null,"url":null,"abstract":"<div><div>The Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CAMK2) family, consisting of subtypes A, B, D, and G, plays a pivotal role in decoding Ca<sup>2+</sup> signals, an essential process in cellular communication and function. Among these, CAMK2G is notably widespread across various body tissues, with predominant expression in neurons and cardiomyocytes, where it significantly influences Ca<sup>2+</sup> signal transduction and the cellular response to stress. Ca<sup>2+</sup> serves as the most plentiful second messenger within the human body, orchestrating critical regulatory roles across numerous physiological and pathological contexts. It is instrumental in managing aspects of the tumor microenvironment, neurodegenerative conditions, cardiovascular diseases, and metabolic disorders. Maintaining Ca<sup>2+</sup> homeostasis is crucial for the proper functioning of different subcellular organelles, impacting overall cellular health and activity. Here, we describe the central connection between CAMK2G and subcellular Ca<sup>2+</sup> homeostasis, highlight the molecular functions of CAMK2G therein, and finally detail the cutting-edge therapeutic strategies targeting CAMK2G.</div></div>","PeriodicalId":8806,"journal":{"name":"Biochemical pharmacology","volume":"242 ","pages":"Article 117323"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CAMK2G in subcellular Ca2+ homeostasis: Molecular mechanisms and therapeutic targeting\",\"authors\":\"Yashi Cao , Zengyue Pan , Xiner Shen , Zhifei Xu , Xiaochun Yang , Bo Yang , Peihua Luo , Hao Yan , Qiaojun He\",\"doi\":\"10.1016/j.bcp.2025.117323\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CAMK2) family, consisting of subtypes A, B, D, and G, plays a pivotal role in decoding Ca<sup>2+</sup> signals, an essential process in cellular communication and function. Among these, CAMK2G is notably widespread across various body tissues, with predominant expression in neurons and cardiomyocytes, where it significantly influences Ca<sup>2+</sup> signal transduction and the cellular response to stress. Ca<sup>2+</sup> serves as the most plentiful second messenger within the human body, orchestrating critical regulatory roles across numerous physiological and pathological contexts. It is instrumental in managing aspects of the tumor microenvironment, neurodegenerative conditions, cardiovascular diseases, and metabolic disorders. Maintaining Ca<sup>2+</sup> homeostasis is crucial for the proper functioning of different subcellular organelles, impacting overall cellular health and activity. Here, we describe the central connection between CAMK2G and subcellular Ca<sup>2+</sup> homeostasis, highlight the molecular functions of CAMK2G therein, and finally detail the cutting-edge therapeutic strategies targeting CAMK2G.</div></div>\",\"PeriodicalId\":8806,\"journal\":{\"name\":\"Biochemical pharmacology\",\"volume\":\"242 \",\"pages\":\"Article 117323\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S000629522500588X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000629522500588X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
CAMK2G in subcellular Ca2+ homeostasis: Molecular mechanisms and therapeutic targeting
The Ca2+/calmodulin-dependent protein kinase II (CAMK2) family, consisting of subtypes A, B, D, and G, plays a pivotal role in decoding Ca2+ signals, an essential process in cellular communication and function. Among these, CAMK2G is notably widespread across various body tissues, with predominant expression in neurons and cardiomyocytes, where it significantly influences Ca2+ signal transduction and the cellular response to stress. Ca2+ serves as the most plentiful second messenger within the human body, orchestrating critical regulatory roles across numerous physiological and pathological contexts. It is instrumental in managing aspects of the tumor microenvironment, neurodegenerative conditions, cardiovascular diseases, and metabolic disorders. Maintaining Ca2+ homeostasis is crucial for the proper functioning of different subcellular organelles, impacting overall cellular health and activity. Here, we describe the central connection between CAMK2G and subcellular Ca2+ homeostasis, highlight the molecular functions of CAMK2G therein, and finally detail the cutting-edge therapeutic strategies targeting CAMK2G.
期刊介绍:
Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.
The journal''s target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.
All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.
While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.